Year-To-Date Revenue Grew 21% and Year-To-Date Adjusted EBITDA Increased by 57% MISSISSAUGA, Ontario / May 28, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 second quarter results for the period ended March 31, 2025, along with a number of important recent achievements and highlights. Brent... Read More